1
|
Thangavel SK, Mohamed Kasim MS, Rengan R. Promoting the Anticancer Activity with Multidentate Furan-2-Carboxamide Functionalized Aroyl Thiourea Chelation in Binuclear Half-Sandwich Ruthenium(II) Complexes. Inorg Chem 2024; 63:7520-7539. [PMID: 38590210 DOI: 10.1021/acs.inorgchem.4c01265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/10/2024]
Abstract
A new set of binuclear arene ruthenium complexes [Ru2(p-cymene)2(k4-N2OS)(L1-L3)Cl2] (Ru2L1-Ru2L3) encompassing furan-2-carboxamide-based aroylthiourea derivatives (H2L1-H2L3) was synthesized and characterized by various spectral and analytical techniques. Single-crystal XRD analysis unveils the N^O and N^S mixed monobasic bidentate coordination of the ligands constructing N, S, Cl/N, O, and Cl legged piano stool octahedral geometry. DFT analysis demonstrates the predilection for the formation of stable arene ruthenium complexes. In vitro antiproliferative activity of the complexes was examined against human cervical (HeLa), breast (MCF-7), and lung (A549) cancerous and noncancerous monkey kidney epithelial (Vero) cells. All the complexes are more efficacious against HeLa and MCF-7 cells with low inhibitory doses (3.86-11.02 μM). Specifically, Ru2L3 incorporating p-cymene and -OCH3 fragments exhibits high lipophilicity, significant cytotoxicity against cancer cells, and lower toxicity on noncancerous cells. Staining analysis indicates the apoptosis-associated cell morphological changes expressively in MCF-7 cells. Mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) analyses reveal that Ru2L3 can raise ROS levels, reduce MMP, and trigger mitochondrial dysfunction-mediated apoptosis. The catalytic oxidation of glutathione (GSH) to its disulfide form (GSSG) by the complexes may simultaneously increase the ROS levels, alluding to their observed cytotoxicity and apoptosis induction. Flow cytometry determined the quantitative classification of late apoptosis and S-phase arrest in MCF-7 and HeLa cells. Western blotting analysis confirmed that the complexes promote apoptosis by upregulating Caspase-3 and Caspase-9 and downregulating BCL-2. Molecular docking studies unfolded the strong binding affinities of the complexes with VEGFR2, an angiogenic signaling receptor, and BCL2, Cyclin D1, and HER2 proteins typically overexpressed on tumor cells.
Collapse
Affiliation(s)
- Sathiya Kamatchi Thangavel
- Centre for Organometallic Chemistry, School of Chemistry, Bharathidasan University, Tiruchirappalli 620 024, India
| | | | - Ramesh Rengan
- Centre for Organometallic Chemistry, School of Chemistry, Bharathidasan University, Tiruchirappalli 620 024, India
| |
Collapse
|
2
|
Patra SA, Sahu G, Das S, Dinda R. Recent Advances in Mitochondria-Localized Luminescent Ruthenium(II) Metallodrugs as Anticancer Agents. ChemMedChem 2023; 18:e202300397. [PMID: 37772783 DOI: 10.1002/cmdc.202300397] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Revised: 09/27/2023] [Accepted: 09/28/2023] [Indexed: 09/30/2023]
Abstract
Presently, the most effective way to transport drugs specifically to mitochondria inside the cells is of pharmacophoric interest, as mitochondria are recognized as one of the most important targets for new drug design in cancer diagnosis. To date, there are many reviews covering the photophysical, photochemical, and anticancer properties of ruthenium(II) based metallodrugs owing to their high interest in biological applications. There are, however, no reviews specifically covering the mitochondria-localized luminescent Ru(II) complexes and their subsequent mitochondria-mediated anticancer activities. Therefore, this review describes the physicochemical basis for the mitochondrial accumulation of ruthenium complexes, their synthetic strategies to localize and monitor the mitochondria in living cells, and their related underlying anticancer results. Finally, we review the related areas from previous works describing the mitochondria-localized ruthenium complexes for the treatment of cancer-related diseases. Along with this, we also deliberate the perspectives and future directions for emerging more bifunctional Ru(II) complexes that can target, image, and kill tumors more efficiently in comparison with the existing mitochondria-targeted cancer therapeutics.
Collapse
Affiliation(s)
- Sushree Aradhana Patra
- Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India
| | - Gurunath Sahu
- Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India
| | - Sanchita Das
- Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India
| | - Rupam Dinda
- Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India
| |
Collapse
|
3
|
Wang N, Ali A, Liu Z, Chi H, Lv Z, Zhao X, Zhang Z, Hao H, Zhang Y, Rahman FU. Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C. Eur J Med Chem 2023; 258:115536. [PMID: 37295260 DOI: 10.1016/j.ejmech.2023.115536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 05/16/2023] [Accepted: 05/30/2023] [Indexed: 06/12/2023]
Abstract
ONS donor ligands L1-L4 were utilized in the preparation of monofunctional dimetallic Ru(η6-arene) complexes (C1-C4). These ONS donor ligand based novel tricoordinated Ru(II) complexes bearing η6-arene co-ligand were prepared for the first time. The current methodology resulted in excellent isolated yields and these complexes were characterized in detail by different spectroscopic and spectrometric techniques. The structures of C1-C2 and C4 were characterized in solid state by single crystal X-ray analysis. The in vitro anticancer analyses showed these novel complexes suppressed the growth of breast (MCF-7), liver (HepG2) and lung (A549) cancer cells. C2 suppressed the growth of these cells in dose-dependent manner revealed form the MTT and crystal violet cell viability assays. Moreover, C2 was observed the most potent complex that was used further in detailed mechanistic analyses in cancer cells. C2 showed good cytotoxic activity at 10 μM dose level as compared to cisplatin or oxaliplatin in these cancer cells. We observed morphological changes in cancer cells upon treatment with C2. Moreover, C2 suppressed the invasion and migration ability of cancer cells. C2 induced cellular senescence to retard cell growth and suppressed the formation of cancer stem cells. Importantly, C2 showed synergistic anticancer effect in combination with cisplatin and Vitamin C to further inhibit cell growth which suggested the potential role of C2 in cancer therapy. Mechanistically, C2 inhibited NOTCH1 dependent signaling pathway to suppress cancer cell invasion, migration and cancer stem cells formation. Thus, these data suggested potential role of C2 in cancer therapy by targeting NOTCH1-dependent signaling to suppress tumorigenesis. The results obtained in this study for these novel monofunctional dimetallic Ru(η6-arene) complexes showed their high anticancer potency and this study will pave to further cytotoxicity exploration on this class of complexes.
Collapse
Affiliation(s)
- Na Wang
- Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, Department of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, People's Republic of China
| | - Amjad Ali
- Institute of Integrative Biosciences, CECOS University of IT and Emerging Sciences, Peshawar, KPK, Pakistan; Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, People's Republic of China
| | - Zongwei Liu
- Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, Department of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, People's Republic of China
| | - Huiqin Chi
- Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, Department of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, People's Republic of China
| | - Zhimin Lv
- Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, Department of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, People's Republic of China
| | - Xing Zhao
- Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, Department of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, People's Republic of China
| | - Zeqing Zhang
- Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, Department of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, People's Republic of China
| | - Huifang Hao
- Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, Department of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, People's Republic of China; School of Life Sciences, Inner Mongolia University, Hohhot, 010021, People's Republic of China
| | - Yongmin Zhang
- Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, Department of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, People's Republic of China; Sorbonne Université, CNRS, Institut Parisien de Chimie Moléculaire, UMR 8232, 4 Place Jussieu, 75005, Paris, France.
| | - Faiz-Ur Rahman
- Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, Department of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, People's Republic of China.
| |
Collapse
|
4
|
Sahu G, Patra SA, Lima S, Das S, Görls H, Plass W, Dinda R. Ruthenium(II)-Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria-Targeted Apoptotic Cell Death. Chemistry 2023; 29:e202202694. [PMID: 36598160 DOI: 10.1002/chem.202202694] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Revised: 01/04/2023] [Accepted: 01/04/2023] [Indexed: 01/05/2023]
Abstract
The reaction of the Ru(PPh3 )3 Cl2 with HL1-3 -OH (-OH stands for the oxime hydroxyl group; HL1 -OH=diacetylmonoxime-S-benzyldithiocarbazonate; HL2 -OH=diacetylmonoxime-S-(4-methyl)benzyldithiocarbazonate; and HL3 -OH=diacetylmonoxime-S-(4-chloro)benzyl-dithiocarbazonate) gives three new ruthenium complexes [RuII (L1-3 -H)(PPh3 )2 Cl] (1-3) (-H stands for imine hydrogen) coordinated with dithiocarbazate imine as the final products. All ruthenium(II) complexes (1-3) have been characterized by elemental (CHNS) analyses, IR, UV-vis, NMR (1 H, 13 C, and 31 P) spectroscopy, HR-ESI-MS spectrometry and also, the structure of 1-2 was further confirmed by single crystal X-ray crystallography. The solution/aqueous stability, hydrophobicity, DNA interactions, and cell viability studies of 1-3 against HeLa, HT-29, and NIH-3T3 cell lines were performed. Cell viability results suggested 3 being the most cytotoxic of the series with IC50 6.9±0.2 μM against HeLa cells. Further, an apoptotic mechanism of cell death was confirmed by cell cycle analysis and Annexin V-FITC/PI double staining techniques. In this regard, the live cell confocal microscopy results revealed that compounds primarily target the mitochondria against HeLa, and HT-29 cell lines. Moreover, these ruthenium complexes elevate the ROS level by inducing mitochondria targeting apoptotic cell death.
Collapse
Affiliation(s)
- Gurunath Sahu
- Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India
| | - Sushree Aradhana Patra
- Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India
| | - Sudhir Lima
- Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India.,Institut für Anorganische und Analytische Chemie, Friedrich-Schiller-Universität Jena, Humboldtstr. 8, 07743, Jena, Germany
| | - Sanchita Das
- Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India
| | - Helmar Görls
- Institut für Anorganische und Analytische Chemie, Friedrich-Schiller-Universität Jena, Humboldtstr. 8, 07743, Jena, Germany
| | - Winfried Plass
- Institut für Anorganische und Analytische Chemie, Friedrich-Schiller-Universität Jena, Humboldtstr. 8, 07743, Jena, Germany
| | - Rupam Dinda
- Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India
| |
Collapse
|
5
|
In silico and biological exploration of greenly synthesized curcumin-incorporated isoniazid Schiff base and its ruthenium complexes. Struct Chem 2022. [DOI: 10.1007/s11224-022-02065-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
6
|
Guin PS, Roy S. Recently Reported Ru-Metal Organic Coordination Complexes and Their Application (A Review). RUSS J GEN CHEM+ 2022. [DOI: 10.1134/s1070363222080242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
7
|
Lin S, Liu C, Zhao X, Han X, Li X, Ye Y, Li Z. Recent Advances of Pyridinone in Medicinal Chemistry. Front Chem 2022; 10:869860. [PMID: 35402370 PMCID: PMC8984125 DOI: 10.3389/fchem.2022.869860] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2022] [Accepted: 03/02/2022] [Indexed: 12/11/2022] Open
Abstract
Pyridinones have been adopted as an important block in medicinal chemistry that could serve as hydrogen bond donors and acceptors. With the help of feasible synthesis routes via established condensation reactions, the physicochemical properties of such a scaffold could be manipulated by adjustment of polarity, lipophilicity, and hydrogen bonding, and eventually lead to its wide application in fragment-based drug design, biomolecular mimetics, and kinase hinge-binding motifs. In addition, most pyridinone derivatives exhibit various biological activities ranging from antitumor, antimicrobial, anti-inflammatory, and anticoagulant to cardiotonic effects. This review focuses on recent contributions of pyridinone cores to medicinal chemistry, and addresses the structural features and structure–activity relationships (SARs) of each drug-like molecule. These advancements contribute to an in-depth understanding of the potential of this biologically enriched scaffold and expedite the development of its new applications in drug discovery.
Collapse
Affiliation(s)
- Shibo Lin
- Department of Pharmacy, Chengdu Second People’s Hospital, Chengdu, China
- *Correspondence: Shibo Lin,
| | - Chun Liu
- Department of Pharmacy, Chengdu Second People’s Hospital, Chengdu, China
| | - Xiaotian Zhao
- Department of Pharmacy, Chengdu Second People’s Hospital, Chengdu, China
| | - Xiao Han
- Department of Pharmacy, Chengdu Second People’s Hospital, Chengdu, China
| | - Xuanhao Li
- Department of Pharmacy, Chengdu Second People’s Hospital, Chengdu, China
| | - Yongqin Ye
- Department of Pharmacy, Chengdu Second People’s Hospital, Chengdu, China
| | - Zheyu Li
- Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China
| |
Collapse
|
8
|
RuII and RuIII complexes with imidazole ligands containing (benzyloxy)pyridinone moiety. MENDELEEV COMMUNICATIONS 2022. [DOI: 10.1016/j.mencom.2022.03.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
9
|
Green LPM, Steel TR, Riisom M, Hanif M, Söhnel T, Jamieson SMF, Wright LJ, Crowley JD, Hartinger CG. Synthetic Strategy Towards Heterodimetallic Half-Sandwich Complexes Based on a Symmetric Ditopic Ligand. Front Chem 2021; 9:786367. [PMID: 34926406 PMCID: PMC8677676 DOI: 10.3389/fchem.2021.786367] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Accepted: 11/02/2021] [Indexed: 11/18/2022] Open
Abstract
Multimetallic complexes have been shown in several examples to possess greater anticancer activity than their monometallic counterparts. The increased activity has been attributed to altered modes of action. We herein report the synthesis of a series of heterodimetallic compounds based on a ditopic ligand featuring 2-pyridylimine chelating motifs and organometallic half-sandwich moieties. The complexes were characterized by a combination of 1H NMR spectroscopy, electrospray ionization mass spectrometry, elemental analysis and single crystal X-ray diffraction. Investigations into the stability of representative complexes in DMSO-d6 and 10% DMSO-d6/D2O revealed the occurrence of solvent-chlorido ligand exchange. Proliferation assays in four human cancer cell lines showed that the Os-Rh complex possessed minimal activity, while all other complexes were inactive.
Collapse
Affiliation(s)
- Lewis P M Green
- School of Chemical Sciences, University of Auckland, Auckland, New Zealand
| | - Tasha R Steel
- School of Chemical Sciences, University of Auckland, Auckland, New Zealand
| | - Mie Riisom
- School of Chemical Sciences, University of Auckland, Auckland, New Zealand.,Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand
| | - Muhammad Hanif
- School of Chemical Sciences, University of Auckland, Auckland, New Zealand
| | - Tilo Söhnel
- School of Chemical Sciences, University of Auckland, Auckland, New Zealand
| | - Stephen M F Jamieson
- Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand
| | - L James Wright
- School of Chemical Sciences, University of Auckland, Auckland, New Zealand
| | - James D Crowley
- Department of Chemistry, University of Otago, Dunedin, New Zealand
| | | |
Collapse
|
10
|
Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands. Coord Chem Rev 2021. [DOI: 10.1016/j.ccr.2021.213950] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
11
|
Steel TR, Tong KK, Söhnel T, Jamieson SM, Wright LJ, Crowley JD, Hanif M, Hartinger CG. Homodinuclear organometallics of ditopic N,N-chelates: Synthesis, reactivity and in vitro anticancer activity. Inorganica Chim Acta 2021. [DOI: 10.1016/j.ica.2020.120220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
12
|
|
13
|
Shakil MS, Parveen S, Rana Z, Walsh F, Movassaghi S, Söhnel T, Azam M, Shaheen MA, Jamieson SMF, Hanif M, Rosengren RJ, Hartinger CG. High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium Complexes. Biomedicines 2021; 9:biomedicines9020123. [PMID: 33513800 PMCID: PMC7912191 DOI: 10.3390/biomedicines9020123] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Revised: 01/20/2021] [Accepted: 01/22/2021] [Indexed: 12/12/2022] Open
Abstract
Hydroxypyr(id)ones are a pharmaceutically important class of compounds that have shown potential in diverse areas of drug discovery. We investigated the 3-hydroxy-4-pyridones 1a-1c and 3-hydroxy-4-thiopyridones 1d-1f as well as their Ru(η6-p-cymene)Cl complexes 2a-2f, and report here the molecular structures of 1b and 1d as determined by X-ray diffraction analysis. Detailed cell biological investigations revealed potent cytotoxic activity, in particular of the 3-hydroxy-4-thiopyridones 1d-1f, while the Ru complexes of both compound types were less potent, despite still showing antiproliferative activity in the low μM range. The compounds did not modulate the cell cycle distribution of cancer cells but were cytostatic in A549 and cytotoxic in NCI-H522 non-small lung cancer cells, among other effects on cancer cells.
Collapse
Affiliation(s)
- Md. Salman Shakil
- Department of Pharmacology and Toxicology, University of Otago, PO Box 56, Dunedin 9016, New Zealand; (M.S.S.); (Z.R.); (M.A.)
| | - Shahida Parveen
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (S.P.); (F.W.); (S.M.); (T.S.)
- Department of Chemistry, University of Sargodha, Sargodha 40100, Pakistan;
| | - Zohaib Rana
- Department of Pharmacology and Toxicology, University of Otago, PO Box 56, Dunedin 9016, New Zealand; (M.S.S.); (Z.R.); (M.A.)
| | - Fearghal Walsh
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (S.P.); (F.W.); (S.M.); (T.S.)
| | - Sanam Movassaghi
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (S.P.); (F.W.); (S.M.); (T.S.)
| | - Tilo Söhnel
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (S.P.); (F.W.); (S.M.); (T.S.)
| | - Mayur Azam
- Department of Pharmacology and Toxicology, University of Otago, PO Box 56, Dunedin 9016, New Zealand; (M.S.S.); (Z.R.); (M.A.)
| | | | - Stephen M. F. Jamieson
- Auckland Cancer Society Research Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand;
| | - Muhammad Hanif
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (S.P.); (F.W.); (S.M.); (T.S.)
- Correspondence: (M.H.); (R.J.R.); (C.G.H.)
| | - Rhonda J. Rosengren
- Department of Pharmacology and Toxicology, University of Otago, PO Box 56, Dunedin 9016, New Zealand; (M.S.S.); (Z.R.); (M.A.)
- Correspondence: (M.H.); (R.J.R.); (C.G.H.)
| | - Christian G. Hartinger
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (S.P.); (F.W.); (S.M.); (T.S.)
- Correspondence: (M.H.); (R.J.R.); (C.G.H.)
| |
Collapse
|
14
|
Adams M, Sullivan MP, Tong KKH, Goldstone DC, Hanif M, Jamieson SMF, Hartinger CG. Mustards-Derived Terpyridine-Platinum Complexes as Anticancer Agents: DNA Alkylation vs Coordination. Inorg Chem 2021; 60:2414-2424. [PMID: 33497565 DOI: 10.1021/acs.inorgchem.0c03317] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The development of bifunctional platinum complexes with the ability to interact with DNA via different binding modes is of interest in anticancer metallodrug research. Therefore, we report platinum(II) terpyridine complexes to target DNA by coordination and/or through a tethered alkylating moiety. The platinum complexes were evaluated for their in vitro antiproliferative properties against the human cancer cell lines HCT116 (colorectal), SW480 (colon), NCI-H460 (non-small cell lung), and SiHa (cervix) and generally exhibited potent antiproliferative activity although lower than their respective terpyridine ligands. 1H NMR spectroscopy and/or ESI-MS studies on the aqueous stability and reactivity with various small biomolecules, acting as protein and DNA model compounds, were used to establish potential modes of action for these complexes. These investigations indicated rapid binding of complex PtL3 to the biomolecules through coordination to the Pt center, while PtL4 in addition alkylated 9-ethylguanine. PtL3 was investigated for its reactivity to the model protein hen egg white lysozyme (HEWL) by protein crystallography which allowed identification of the Nδ1 atom of His15 as the binding site.
Collapse
Affiliation(s)
- Muneebah Adams
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
| | - Matthew P Sullivan
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.,School of Biological Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
| | - Kelvin K H Tong
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.,Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
| | - David C Goldstone
- School of Biological Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
| | - Muhammad Hanif
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
| | - Stephen M F Jamieson
- Auckland Cancer Society Research Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
| | - Christian G Hartinger
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.,Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
| |
Collapse
|
15
|
Studer V, Anghel N, Desiatkina O, Felder T, Boubaker G, Amdouni Y, Ramseier J, Hungerbühler M, Kempf C, Heverhagen JT, Hemphill A, Ruprecht N, Furrer J, Păunescu E. Conjugates Containing Two and Three Trithiolato-Bridged Dinuclear Ruthenium(II)-Arene Units as In Vitro Antiparasitic and Anticancer Agents. Pharmaceuticals (Basel) 2020; 13:E471. [PMID: 33339451 PMCID: PMC7767221 DOI: 10.3390/ph13120471] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 12/10/2020] [Accepted: 12/11/2020] [Indexed: 12/15/2022] Open
Abstract
The synthesis, characterization, and in vitro antiparasitic and anticancer activity evaluation of new conjugates containing two and three dinuclear trithiolato-bridged ruthenium(II)-arene units are presented. Antiparasitic activity was evaluated using transgenic Toxoplasmagondii tachyzoites constitutively expressing β-galactosidase grown in human foreskin fibroblasts (HFF). The compounds inhibited T.gondii proliferation with IC50 values ranging from 90 to 539 nM, and seven derivatives displayed IC50 values lower than the reference compound pyrimethamine, which is currently used for treatment of toxoplasmosis. Overall, compound flexibility and size impacted on the anti-Toxoplasma activity. The anticancer activity of 14 compounds was assessed against cancer cell lines A2780, A2780cisR (human ovarian cisplatin sensitive and resistant), A24, (D-)A24cisPt8.0 (human lung adenocarcinoma cells wild type and cisPt resistant subline). The compounds displayed IC50 values ranging from 23 to 650 nM. In A2780cisR, A24 and (D-)A24cisPt8.0 cells, all compounds were considerably more cytotoxic than cisplatin, with IC50 values lower by two orders of magnitude. Irrespective of the nature of the connectors (alkyl/aryl) or the numbers of the di-ruthenium units (two/three), ester conjugates 6-10 and 20 exhibited similar antiproliferative profiles, and were more cytotoxic than amide analogues 11-14, 23, and 24. Polynuclear conjugates with multiple trithiolato-bridged di-ruthenium(II)-arene moieties deserve further investigation.
Collapse
Affiliation(s)
- Valentin Studer
- Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland; (V.S.); (O.D.); (T.F.)
| | - Nicoleta Anghel
- Vetsuisse Faculty, Institute of Parasitology, University of Bern, Länggassstrasse 122, CH-3012 Bern, Switzerland; (N.A.); (G.B.); (Y.A.); (J.R.)
| | - Oksana Desiatkina
- Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland; (V.S.); (O.D.); (T.F.)
| | - Timo Felder
- Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland; (V.S.); (O.D.); (T.F.)
| | - Ghalia Boubaker
- Vetsuisse Faculty, Institute of Parasitology, University of Bern, Länggassstrasse 122, CH-3012 Bern, Switzerland; (N.A.); (G.B.); (Y.A.); (J.R.)
| | - Yosra Amdouni
- Vetsuisse Faculty, Institute of Parasitology, University of Bern, Länggassstrasse 122, CH-3012 Bern, Switzerland; (N.A.); (G.B.); (Y.A.); (J.R.)
- Laboratoire de Parasitologie, Institution de la Recherche et de l’Enseignement Supérieur Agricoles, École Nationale de Médecine Vétérinaire de Sidi Thabet, University of Manouba, Sidi Thabet 2020, Tunisia
| | - Jessica Ramseier
- Vetsuisse Faculty, Institute of Parasitology, University of Bern, Länggassstrasse 122, CH-3012 Bern, Switzerland; (N.A.); (G.B.); (Y.A.); (J.R.)
| | - Martin Hungerbühler
- Department of BioMedical Research, Experimental Radiology, University of Bern, CH-3008 Bern, Switzerland; (M.H.); (C.K.); (J.T.H.)
- Department of Diagnostic, Interventional and Pediatric Radiology, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland
| | - Christoph Kempf
- Department of BioMedical Research, Experimental Radiology, University of Bern, CH-3008 Bern, Switzerland; (M.H.); (C.K.); (J.T.H.)
- Department of Diagnostic, Interventional and Pediatric Radiology, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland
| | - Johannes Thomas Heverhagen
- Department of BioMedical Research, Experimental Radiology, University of Bern, CH-3008 Bern, Switzerland; (M.H.); (C.K.); (J.T.H.)
- Department of Diagnostic, Interventional and Pediatric Radiology, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland
| | - Andrew Hemphill
- Vetsuisse Faculty, Institute of Parasitology, University of Bern, Länggassstrasse 122, CH-3012 Bern, Switzerland; (N.A.); (G.B.); (Y.A.); (J.R.)
| | - Nico Ruprecht
- Department of BioMedical Research, Experimental Radiology, University of Bern, CH-3008 Bern, Switzerland; (M.H.); (C.K.); (J.T.H.)
- Department of Diagnostic, Interventional and Pediatric Radiology, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland
| | - Julien Furrer
- Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland; (V.S.); (O.D.); (T.F.)
| | - Emilia Păunescu
- Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland; (V.S.); (O.D.); (T.F.)
| |
Collapse
|
16
|
Sudhindra P, Ajay Sharma S, Roy N, Moharana P, Paira P. Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: A review. Polyhedron 2020. [DOI: 10.1016/j.poly.2020.114827] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
17
|
Chen C, Zhou L, Xie B, Wang Y, Ren L, Chen X, Cen B, Lv H, Wang H. Novel fast-acting pyrazole/pyridine-functionalized N-heterocyclic carbene silver complexes assembled with nanoparticles show enhanced safety and efficacy as anticancer therapeutics. Dalton Trans 2020; 49:2505-2516. [PMID: 32022055 DOI: 10.1039/c9dt04751d] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
In this study, we designed and synthesized four novel multi-nuclear silver complexes (1-4) coordinated with pyrazole- or pyridine-functionalized N-heterocyclic carbene (NHC) ligands. The crystal structures of the silver-NHC complexes were confirmed by X-ray diffraction analysis. In vitro assays showed that the silver-NHC complexes effectively killed a broad range of cancer cells after short-term drug exposure, serving as fast-acting cytotoxic agents. Of note, in cisplatin-resistant A549 cancer cells, the silver complexes were not cross-resistant with the clinically used cisplatin agent. Detailed mechanistic studies revealed that complex 2 triggered caspase-independent cell necrosis associated with intracellular reactive oxygen species (ROS) production and mitochondrial membrane potential (MMP) depletion. By exploiting a facile nano-assembly process, silver-NHC complexes 1, 2 and 4 were successfully integrated into the hydrophobic cores of amphiphilic matrices (DSPE-PEG2K), enabling systemic injection. The silver complex-loaded nanotherapeutics (1-NPs, 2-NPs, and 4-NPs) showed high safety margins with reduced systemic drug toxicities relative to cisplatin in animals. Furthermore, in a xenograft model of human colorectal cancer, the administration of the nanotherapeutics resulted in a marked inhibition of tumor progression.
Collapse
Affiliation(s)
- Chao Chen
- The First Affiliated Hospital, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, School of Medicine, Zhejiang University, Hangzhou, 310003, PR China. and College of Life Sciences, Huzhou University, Huzhou, 313000, PR China
| | - Liqian Zhou
- The First Affiliated Hospital, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, School of Medicine, Zhejiang University, Hangzhou, 310003, PR China.
| | - Binbin Xie
- Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, PR China
| | - Yuchen Wang
- The First Affiliated Hospital, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, School of Medicine, Zhejiang University, Hangzhou, 310003, PR China.
| | - Lulu Ren
- Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, PR China
| | - Xiaona Chen
- The First Affiliated Hospital, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, School of Medicine, Zhejiang University, Hangzhou, 310003, PR China.
| | - Beini Cen
- The First Affiliated Hospital, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, School of Medicine, Zhejiang University, Hangzhou, 310003, PR China.
| | - He Lv
- College of Life Sciences, Huzhou University, Huzhou, 313000, PR China
| | - Hangxiang Wang
- The First Affiliated Hospital, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, School of Medicine, Zhejiang University, Hangzhou, 310003, PR China.
| |
Collapse
|
18
|
Synthesis and anti-cancer activity of bis-amino-phosphine ligand and its ruthenium(II) complexes. Bioorg Med Chem Lett 2020; 30:127492. [DOI: 10.1016/j.bmcl.2020.127492] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2020] [Revised: 08/06/2020] [Accepted: 08/09/2020] [Indexed: 12/30/2022]
|
19
|
Bertrand B, Gontard G, Botuha C, Salmain M. Pincer‐Based Heterobimetallic Pt(II)/Ru(II), Pt(II)/Ir(III), and Pt(II)/Cu(I) Complexes: Synthesis and Evaluation of Antiproliferative Properties. Eur J Inorg Chem 2020. [DOI: 10.1002/ejic.202000717] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Benoît Bertrand
- CNRS, Institut Parisien de Chimie Moléculaire (IPCM) Sorbonne Université 75005 Paris France
| | - Geoffrey Gontard
- CNRS, Institut Parisien de Chimie Moléculaire (IPCM) Sorbonne Université 75005 Paris France
| | - Candice Botuha
- CNRS, Institut Parisien de Chimie Moléculaire (IPCM) Sorbonne Université 75005 Paris France
| | - Michèle Salmain
- CNRS, Institut Parisien de Chimie Moléculaire (IPCM) Sorbonne Université 75005 Paris France
| |
Collapse
|
20
|
Wilson CS, Prior TJ, Sandland J, Savoie H, Boyle RW, Murray BS. Homo‐ and Hetero‐dinuclear Arene‐Linked Osmium(II) and Ruthenium(II) Organometallics: Probing the Impact of Metal Variation on Reactivity and Biological Activity. Chemistry 2020; 26:11593-11603. [DOI: 10.1002/chem.202002052] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Revised: 05/31/2020] [Indexed: 12/16/2022]
Affiliation(s)
- Christopher S. Wilson
- Department of Chemistry and Biochemistry University of Hull Cottingham Road Hull HU6 7RX UK
| | - Timothy J. Prior
- Department of Chemistry and Biochemistry University of Hull Cottingham Road Hull HU6 7RX UK
| | - Jordon Sandland
- Department of Chemistry and Biochemistry University of Hull Cottingham Road Hull HU6 7RX UK
| | - Huguette Savoie
- Department of Chemistry and Biochemistry University of Hull Cottingham Road Hull HU6 7RX UK
| | - Ross W. Boyle
- Department of Chemistry and Biochemistry University of Hull Cottingham Road Hull HU6 7RX UK
| | - Benjamin S. Murray
- Department of Chemistry and Biochemistry University of Hull Cottingham Road Hull HU6 7RX UK
| |
Collapse
|
21
|
Rhodium(III) complexes of 1-Alkyl-2-{(o-thioalkyl) phenylazo}imidazoles: synthesis, structure, spectral characterization, DNA binding study and DFT calculation. TRANSIT METAL CHEM 2020. [DOI: 10.1007/s11243-020-00414-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
22
|
Štarha P, Hošek J, Trávníček Z, Dvořák Z. Cytotoxic dimeric half‐sandwich Ru(II), Os(II) and Ir(III) complexes containing the 4,4′‐biphenyl‐based bridging ligands. Appl Organomet Chem 2020. [DOI: 10.1002/aoc.5785] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- Pavel Štarha
- Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of SciencePalacký University in Olomouc Šlechtitelů 27 Olomouc 783 71 Czech Republic
| | - Jan Hošek
- Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of SciencePalacký University in Olomouc Šlechtitelů 27 Olomouc 783 71 Czech Republic
| | - Zdeněk Trávníček
- Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of SciencePalacký University in Olomouc Šlechtitelů 27 Olomouc 783 71 Czech Republic
| | - Zdeněk Dvořák
- Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of SciencePalacký University in Olomouc Šlechtitelů 27 Olomouc 783 71 Czech Republic
- Department of Cell Biology and Genetics, Faculty of SciencePalacký University in Olomouc Šlechtitelů 27 Olomouc 783 71 Czech Republic
| |
Collapse
|
23
|
Affiliation(s)
- Shazia Parveen
- Faculty of Science, Chemistry Department Taibah University Yanbu Branch Yanbu 46423 Saudi Arabia
| |
Collapse
|
24
|
Kavukcu SB, Şahin O, Seda Vatansever H, Kurt FO, Korkmaz M, Kendirci R, Pelit L, Türkmen H. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes. Bioorg Chem 2020; 99:103793. [PMID: 32278205 DOI: 10.1016/j.bioorg.2020.103793] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2019] [Revised: 03/16/2020] [Accepted: 03/23/2020] [Indexed: 01/03/2023]
Abstract
A series of mono and bimetallic ruthenium(II) arene complexes bearing diamine (Ru1-6) were prepared and fully characterized by 1H, 13C, 19F, and 31P NMR spectroscopy and elemental analysis. The crystal structure of the bimetallic complex (Ru5) was determined by X-ray crystallography. Monometallic analogues (Ru1-3) were synthesized to investigate the contributions of ruthenium and the other organic groups (aren, ethylenediamine, butyl) to the activity. The electrochemical behaviors of mono and bimetallic complexes were obtained from the relationship between cyclic voltammetry (CV) and the biological activities of the compounds. The cytotoxic activities of the complexes (Ru1-6) were tested against wide-scale cancer cell lines, namely HeLa, MDA-MB-231, DU-145, LNCaP, Hep-G2, Saos-2, PC-3, and MCF-7, and normal cell lines 3T3-L1 and Vero. Diamine Ru(II) arene complexes have unique biological characteristics and they are promising models for new anticancer drug development. MTT analysis reveals that each synthesized Ru complex showed cytotoxic activity towards the different cancer cells. In particular, three Ru complexes (Ru3, Ru5 and Ru6) showed less toxic effects on the cancer cells than the others. These novel Ru complexes affected both cancer and normal cell lines. As they had a toxic effect on the cells, the dosage applied should be tested before being used for in vivo applications. Cytotoxicity tests have shown that the bimetallic complex Ru6 was effective on all cancer cells. The effect of bimetallic enhancement on cancer cell lines, the systematic variation of the intermetallic distance and the ligand donor properties of the mono and bimetallic complexes were explored based on the cytotoxic activity. The interaction with FS-DNA and the stability/aquation of the complexes (Ru3 and Ru6) were investigated with 1H NMR spectroscopy. The binding modes between the complexes (Ru3 and Ru6) and DNA were investigated via UV-Vis spectroscopy.
Collapse
Affiliation(s)
| | - Onur Şahin
- University of Sinop, Scientific and Technological Research Application and Research Center, Sinop, Turkey
| | - Hafize Seda Vatansever
- University of Manisa Celal Bayar, Faculty of Medicine, Department of Histology-Embryology, 45030 Manisa, Turkey; Research Centre of Experimental Health Sciences (DESAM), Near East University, Mersin-10, Cyprus
| | - Feyzan Ozdal Kurt
- University of Manisa Celal Bayar, Faculty of Sciences and Letters, Department of Biology, 45030 Manisa, Turkey
| | - Mehmet Korkmaz
- University of Manisa Celal Bayar, Faculty of Medicine, Department of Medical Biology, 45030 Manisa, Turkey
| | - Remziye Kendirci
- University of Manisa Celal Bayar, Faculty of Medicine, Department of Histology-Embryology, 45030 Manisa, Turkey
| | - Levent Pelit
- University of Ege, Faculty of Science, Department of Chemistry, 35100 Izmir, Turkey
| | - Hayati Türkmen
- University of Ege, Faculty of Science, Department of Chemistry, 35100 Izmir, Turkey.
| |
Collapse
|
25
|
Sanad SMH, Mekky AEM. Synthesis, in-vitro antibacterial and anticancer screening of novel nicotinonitrile-coumarin hybrids utilizing piperazine citrate. SYNTHETIC COMMUN 2020. [DOI: 10.1080/00397911.2020.1743318] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
| | - Ahmed E. M. Mekky
- Chemistry Department, Faculty of Science, Cairo University, Giza, Egypt
| |
Collapse
|
26
|
Hanif M, Hartinger CG. From the hypothesis-driven development of organometallic anticancer drugs to new methods in mode of action studies. Med Chem 2020. [DOI: 10.1016/bs.adioch.2019.10.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
27
|
Vuradi RK, Nambigari N, Pendyala P, Gopu S, Kotha LR, G D, M VR, Sirasani S. Study of Anti‐Apoptotic mechanism of Ruthenium (II)Polypyridyl Complexes via RT‐PCR and DNA binding. Appl Organomet Chem 2019. [DOI: 10.1002/aoc.5332] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
| | - Navaneetha Nambigari
- Department of ChemistryOsmania University Hyderabad 500007 India
- Department of Chemistry, University College of Science, SaifabadOsmania University Hyderabad 500 004 India
| | - Pushpanjali Pendyala
- Institute of Genetics & Hospital for Genetic Diseases, BegumpetOsmania University Hyderabad 500 016 India
| | - Srinivas Gopu
- Department of ChemistryOsmania University Hyderabad 500007 India
| | | | - Deepika G
- Institute of Genetics & Hospital for Genetic Diseases, BegumpetOsmania University Hyderabad 500 016 India
| | - Vinoda Rani M
- Department of PhysicsOsmania University Hyderabad 500007 India
| | | |
Collapse
|
28
|
Mono- and binuclear Ru(II) arene complexes with (fluoro substituted) picolinic acid: Synthesis, characterization and cytotoxicity. J Organomet Chem 2019. [DOI: 10.1016/j.jorganchem.2019.120966] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
29
|
Mutua GK, Bellam R, Jaganyi D, Mambanda A. The role of N,N-chelate ligand on the reactivity of (η6-p-cymene)Ru(II) complexes: kinetics, DNA and protein interaction studies. J COORD CHEM 2019. [DOI: 10.1080/00958972.2019.1676893] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Gershom Kyalo Mutua
- School of Chemistry and Physics, University of KwaZulu-Natal, Scottsville, Pietermaritzburg, South Africa
- Department of Pure and Applied Chemistry, Masinde Muliro University of Science and Technology, Kakamega, Kenya
| | - Rajesh Bellam
- School of Chemistry and Physics, University of KwaZulu-Natal, Scottsville, Pietermaritzburg, South Africa
| | - Deogratius Jaganyi
- School of Science, College of Science and Technology, University of Rwanda, Kigali, Rwanda
- Department of Chemistry, Faculty of Applied Sciences, Durban University of Technology, Durban, South Africa
| | - Allen Mambanda
- School of Chemistry and Physics, University of KwaZulu-Natal, Scottsville, Pietermaritzburg, South Africa
| |
Collapse
|
30
|
|
31
|
Ma DL, Wu C, Wu KJ, Leung CH. Iridium(III) Complexes Targeting Apoptotic Cell Death in Cancer Cells. Molecules 2019; 24:molecules24152739. [PMID: 31357712 PMCID: PMC6696146 DOI: 10.3390/molecules24152739] [Citation(s) in RCA: 52] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2019] [Revised: 07/20/2019] [Accepted: 07/26/2019] [Indexed: 11/16/2022] Open
Abstract
Targeting apoptosis is a principal strategy in the design of anticancer drugs. In recent years, non-platinum-based scaffolds have been exploited as viable candidates for the exploitation of anticancer agents with potentially lower toxicity than the widely used cisplatin analogues. This review highlights the latest advances in developing iridium(III) complexes as anticancer agents that act particularly via targeting apoptotic cell death in cancer cells.
Collapse
Affiliation(s)
- Dik-Lung Ma
- Department of Chemistry, Faculty of Science, Hong Kong Baptist University, Kowloon, Hong Kong SAR 999077, China.
| | - Chun Wu
- Department of Chemistry, Faculty of Science, Hong Kong Baptist University, Kowloon, Hong Kong SAR 999077, China
| | - Ke-Jia Wu
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, Macau SAR 999078, China
| | - Chung-Hang Leung
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, Macau SAR 999078, China.
| |
Collapse
|
32
|
Teles CM, Lammoglia LC, Juliano MA, Ruiz ALTG, Candido TZ, de Carvalho JE, Lima CSP, Abbehausen C. Novel anticancer Pd II complexes: The effect of the conjugation of transferrin binding peptide and the nature of halogen coordinated on antitumor activity. J Inorg Biochem 2019; 199:110754. [PMID: 31401348 DOI: 10.1016/j.jinorgbio.2019.110754] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2019] [Revised: 06/14/2019] [Accepted: 06/23/2019] [Indexed: 01/06/2023]
Abstract
A series of PdII complexes with bis-(2-pyridylmethyl)glycine as a ligand of formula [PdX(bis-(2-pyridylmethyl)glycine)] where X = Cl, Br, I were prepared and the effect of the halogen nature in the antitumor activity of eight tumorigenic and one non-tumorigenic cell line was evaluated. The chloride derivative was further functionalized with a transferrin receptor binding peptide, generating the first PdII based metallopeptide. Its antitumor activity was also evaluated. However, among all the complexes, the chloride and iodine parent compounds showed the lowest GI50 values in the panel evaluated, and lowest GI50 than cisplatin in several cell lines. In contrast, the bromine derivative showed higher values of GI50 than chloride and iodine (around 30 - 50 μM). The same trend was observed for the bovine serum albumin binding constant with higher values for iodine, chlorine, and bromine in this order. In aqueous solution, the chloride is exchanged by water while the bromine and iodine are not. DNA was evaluated as a target and showed no significative interaction for all the compounds. The results suggest sulfur-rich proteins and not DNA as a target. This report represents the first PdII metallopeptide reported, its evaluation in solution and antitumor activity. This work opens the possibilities for further functionalization of PdII complexes and the importance of the halogen coordination in the design of novel metallodrugs.
Collapse
Affiliation(s)
- C M Teles
- Institute of Chemistry, University of Campinas - UNICAMP, PO Box 6154, 13083-970 Campinas, SP, Brazil
| | - L C Lammoglia
- Faculty of Pharmaceutical Sciences, University of Campinas, UNICAMP, 13083-871 Campinas, SP, Brazil
| | - M A Juliano
- Universidade Federal de São Paulo, Escola Paulista de Medicina, UNIFESP, 04063-062 São Paulo, SP, Brazil
| | - A L T G Ruiz
- Faculty of Pharmaceutical Sciences, University of Campinas, UNICAMP, 13083-871 Campinas, SP, Brazil
| | - T Z Candido
- Faculty of Medical Sciences, University of Campinas, UNICAMP, 13083-970 Campinas, SP, Brazil
| | - J E de Carvalho
- Faculty of Pharmaceutical Sciences, University of Campinas, UNICAMP, 13083-871 Campinas, SP, Brazil
| | - C S P Lima
- Faculty of Medical Sciences, University of Campinas, UNICAMP, 13083-970 Campinas, SP, Brazil
| | - C Abbehausen
- Institute of Chemistry, University of Campinas - UNICAMP, PO Box 6154, 13083-970 Campinas, SP, Brazil.
| |
Collapse
|
33
|
Gopu S, Ravi Kumar V, Laxma Reddy K, Venkat Reddy P, Sirasani S. DNA binding, photocleavage, antimicrobial and cytotoxic properties of Ru(II) polypyridyl complexes containing BOPIP ligand, (BOPIP = {2-(4-(benzyloxy) phenyl)-1H-imidazo [4,5-f] [1,2]phenanthroline}). NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2019; 38:349-373. [PMID: 30890029 DOI: 10.1080/15257770.2018.1549329] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
A novel ligand BOPIP (BOPIP = {2-(4-(benzyloxy)phenyl)-1H-imidazo[4,5-f][1,10]phenanthroline}) and its mononuclear Ru(II) polypyridyl complexes [Ru(phen)2 BOPIP]2+(1) (phen = 1,10-Phenanthrolene), [Ru(bpy)2 BOPIP]2+(2) (bpy = 2,2' bipyridyl), [Ru(dmb)2 BOPIP]2+(3) (dmb = 4, 4' -dimethyl 2, 2' -bipyridine), [Ru(Hdpa)2 BOPIP]2+(4) (Hdpa = 2,2'dipyridylamine) have been synthesized successfully and characterized by elemental analysis, UV-vis, IR, 1H, 13 C-NMR, and ESI-MS Spectroscopy. The interaction of these complexes with CT-DNA was studied using absorption, emission techniques, viscosity measurements and molecular docking studies. The docking study also supports the binding ability of complexes obtained through the absorption and emission techniques. These studies reveal that the Four Ru(II) polypyridyl complexes bind to DNA predominantly by intercalation. The Antimicrobial activity and cytotoxicity of these complexes are also reported.
Collapse
Affiliation(s)
- Srinivas Gopu
- a Department of Chemistry , University College of Science, Osmania University , Hyderabad , Telangana State , India.,b Department of Chemistry , Government Degree College Manthani , Peddapalli District , Telangana State , India
| | - Vuradi Ravi Kumar
- a Department of Chemistry , University College of Science, Osmania University , Hyderabad , Telangana State , India
| | - Kotha Laxma Reddy
- a Department of Chemistry , University College of Science, Osmania University , Hyderabad , Telangana State , India
| | - Putta Venkat Reddy
- a Department of Chemistry , University College of Science, Osmania University , Hyderabad , Telangana State , India
| | - Satyanarayana Sirasani
- a Department of Chemistry , University College of Science, Osmania University , Hyderabad , Telangana State , India
| |
Collapse
|
34
|
Zhao J, Li S, Wang X, Xu G, Gou S. Dinuclear Organoruthenium Complexes Exhibiting Antiproliferative Activity through DNA Damage and a Reactive-Oxygen-Species-Mediated Endoplasmic Reticulum Stress Pathway. Inorg Chem 2019; 58:2208-2217. [DOI: 10.1021/acs.inorgchem.8b03447] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
35
|
Parveen S, Hanif M, Leung E, Tong KKH, Yang A, Astin J, De Zoysa GH, Steel TR, Goodman D, Movassaghi S, Söhnel T, Sarojini V, Jamieson SMF, Hartinger CG. Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity. Chem Commun (Camb) 2019; 55:12016-12019. [DOI: 10.1039/c9cc03822a] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Dinuclear RhIII(Cp*) and IrIII(Cp*) complexes demonstrated potent in vitro anticancer activity while exhibiting low toxicity in haemolysis studies and in vivo zebrafish models.
Collapse
Affiliation(s)
- Shahida Parveen
- School of Chemical Sciences
- University of Auckland
- Auckland 1142
- New Zealand
| | - Muhammad Hanif
- School of Chemical Sciences
- University of Auckland
- Auckland 1142
- New Zealand
| | - Euphemia Leung
- Auckland Cancer Society Research Centre
- University of Auckland
- Auckland 1142
- New Zealand
| | - Kelvin K. H. Tong
- School of Chemical Sciences
- University of Auckland
- Auckland 1142
- New Zealand
| | - Annie Yang
- Department of Molecular Medicine and Pathology
- University of Auckland
- Auckland 1142
- New Zealand
| | - Jonathan Astin
- Department of Molecular Medicine and Pathology
- University of Auckland
- Auckland 1142
- New Zealand
| | - Gayan H. De Zoysa
- School of Chemical Sciences
- University of Auckland
- Auckland 1142
- New Zealand
| | - Tasha R. Steel
- School of Chemical Sciences
- University of Auckland
- Auckland 1142
- New Zealand
| | - David Goodman
- School of Chemical Sciences
- University of Auckland
- Auckland 1142
- New Zealand
| | - Sanam Movassaghi
- School of Chemical Sciences
- University of Auckland
- Auckland 1142
- New Zealand
| | - Tilo Söhnel
- School of Chemical Sciences
- University of Auckland
- Auckland 1142
- New Zealand
| | | | | | | |
Collapse
|
36
|
Ruthenium coordination compounds of biological and biomedical significance. DNA binding agents. Coord Chem Rev 2018. [DOI: 10.1016/j.ccr.2018.07.012] [Citation(s) in RCA: 85] [Impact Index Per Article: 14.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
37
|
Reddy V, Dayal D, Szalda DJ, Cosenza SC, Reddy MR. Synthesis and characterization of triruthenium carbonyl incorporating 4-pyridones as potential antitumor agents. J Organomet Chem 2018. [DOI: 10.1016/j.jorganchem.2018.07.023] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
38
|
Rubio‐Magnieto J, Kajouj S, Di Meo F, Fossépré M, Trouillas P, Norman P, Linares M, Moucheron C, Surin M. Binding Modes and Selectivity of Ruthenium Complexes to Human Telomeric DNA G‐Quadruplexes. Chemistry 2018; 24:15577-15588. [DOI: 10.1002/chem.201802147] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2018] [Revised: 07/12/2018] [Indexed: 02/05/2023]
Affiliation(s)
- Jenifer Rubio‐Magnieto
- Laboratory for Chemistry of Novel Materials Center for Innovation in Materials and Polymers University of Mons-UMONS 20 Place du Parc 7000 Mons Belgium
- Current address: Bioinspired Supramolecular Chemistry and Materials group Departament de Química Inorgànica i Orgànica Universitat Jaume I Avda Sos Baynat s/n E-12071 Castelló Spain
| | - Sofia Kajouj
- Chimie Organique et Photochimie CP160/08 Université libre de Bruxelles 50 avenue F. D. Roosevelt 1050 Bruxelles Belgium
| | - Florent Di Meo
- INSERM U1248 IPPRITT University of Limoges School of Pharmacy 2 rue du Dr. Marcland 87025 Limoges France
| | - Mathieu Fossépré
- Laboratory for Chemistry of Novel Materials Center for Innovation in Materials and Polymers University of Mons-UMONS 20 Place du Parc 7000 Mons Belgium
| | - Patrick Trouillas
- INSERM U1248 IPPRITT University of Limoges School of Pharmacy 2 rue du Dr. Marcland 87025 Limoges France
- RCPTM Palacký University Faculty of Sciences Šlechtitelů 27 78371 Olomouc Czech Republic
| | - Patrick Norman
- Department of Theoretical Chemistry and Biology School of Engineering Sciences in Chemistry Biotechnology and Health KTH Royal Institute of Technology SE-106 91 Stockholm Sweden
| | - Mathieu Linares
- Department of Theoretical Chemistry and Biology School of Engineering Sciences in Chemistry Biotechnology and Health KTH Royal Institute of Technology SE-106 91 Stockholm Sweden
- Swedish e-Science Research Centre (SeRC) KTH Royal Institute of Technology 104 50 Stockholm Sweden
| | - Cécile Moucheron
- Chimie Organique et Photochimie CP160/08 Université libre de Bruxelles 50 avenue F. D. Roosevelt 1050 Bruxelles Belgium
| | - Mathieu Surin
- Laboratory for Chemistry of Novel Materials Center for Innovation in Materials and Polymers University of Mons-UMONS 20 Place du Parc 7000 Mons Belgium
| |
Collapse
|
39
|
Rahman FU, Bhatti MZ, Ali A, Duong HQ, Zhang Y, Ji X, Lin Y, Wang H, Li ZT, Zhang DW. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Eur J Med Chem 2018; 157:1480-1490. [PMID: 30282320 DOI: 10.1016/j.ejmech.2018.08.054] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2018] [Revised: 08/15/2018] [Accepted: 08/18/2018] [Indexed: 12/22/2022]
Abstract
A series of bis-salicylaldimine ligands bearing two ON-donor functions were reacted with dichloro(p-cymene)ruthenium(II) dimer in the presence of base (NaOAc) and a series of four dimetallic Ru(II) arene complexes (Ru(p-cymene))2(bis-salicylaldimine)Cl2 (C1C4) were prepared. These complexes were obtained in excellent isolated yields and characterized in detail by using different spectroscopic techniques. The structure of C1 was also determined in solid state by single crystal X-ray analysis. These complexes were studied for their cytotoxic effect against three different types of human cancer cells including hepatocellular carcinoma (HepG2), non-small-cell lung cancer (A549) and breast cancer (MCF-7) cells by MTT assay. These complexes showed considerable cytotoxic effect in all the above-mentioned cell lines that was comparable to the effect of cisplatin. C1 and C2 showed moderate anticancer effect while C3 and C4 showed reasonable cytotoxicity. We found the cytotoxicity was increased in series from C1 to C4 representing the effect of ligand modification from small to bulky group at the amine functionality of the salicylaldimine. We selected C3 and C4 for mechanistic anticancer study in MCF-7 cells. The acridine orange/ethidium bromide and DAPI staining assays of MCF-7 cells treated with Ru(II) complexes showed apoptosis in cancer cells. Similarly, these complexes induced p53 protein expression in MCF-7 cells. Further, increased mRNA levels of p63, p73, PUMA, BAX and NOXA genes were observed in response to the treatment with C3 and C4, while cyclinD1, MMP3 and ID1 gene expression was significantly reduced. We found reduced invasion ability in breast cancer cells treated with C3 and C4. Taken together, we demonstrated that bis-salicylaldimine based dimetallic Ru-(p-cymene) complexes exerts anticancer effects by p53 pathway, suggesting the promising chemotherapeutic potentials of these Ru(II) complexes for the treatment of cancer. This study may further pave for their in depth in vitro or in vivo anticancer investigations.
Collapse
Affiliation(s)
- Faiz-Ur Rahman
- Department of Chemistry, Fudan University, 220 Handan Road, Shanghai, 200433, China; Center for Supramolecular Material and Catalysis, Department of Chemistry, Shanghai University, Shanghai, 200444, China
| | - Muhammad Zeeshan Bhatti
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China; Department of Molecular Medicine, National University of Medical Sciences, Rawalpindi, Pakistan
| | - Amjad Ali
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China; Institute of Integrative Biosciences, CECOS University of IT and Emerging Sciences, Peshawar, KPK, Pakistan
| | - Hong-Quan Duong
- Institute of Research and Development, Duy Tan University, K7/25 Quang Trung, Danang, 550000, Viet Nam; Department of Cancer Research, Vinmec Research Institute of Stem Cell and Gene Technology, 458 Minh Khai, Hanoi, 100000, Viet Nam
| | - Yao Zhang
- Department of Chemistry, Fudan University, 220 Handan Road, Shanghai, 200433, China
| | - Xinjian Ji
- Department of Chemistry, Fudan University, 220 Handan Road, Shanghai, 200433, China
| | - Yuejian Lin
- Department of Chemistry, Fudan University, 220 Handan Road, Shanghai, 200433, China
| | - Hui Wang
- Department of Chemistry, Fudan University, 220 Handan Road, Shanghai, 200433, China.
| | - Zhan-Ting Li
- Department of Chemistry, Fudan University, 220 Handan Road, Shanghai, 200433, China
| | - Dan-Wei Zhang
- Department of Chemistry, Fudan University, 220 Handan Road, Shanghai, 200433, China.
| |
Collapse
|
40
|
Milutinović MM, Elmroth SKC, Davidović G, Rilak A, Klisurić OR, Bratsos I, Bugarčić ŽD. Kinetic and mechanistic study on the reactions of ruthenium(ii) chlorophenyl terpyridine complexes with nucleobases, oligonucleotides and DNA. Dalton Trans 2018; 46:2360-2369. [PMID: 28139789 DOI: 10.1039/c6dt04254f] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
In this study, we investigated the ability of Ru(ii) polypyridyl complexes to act as DNA binders. The substitution reactions of three Ru(ii) chlorophenyl terpyridine complexes, i.e. [Ru(Cl-Ph-tpy)(en)Cl]Cl (1), [Ru(Cl-Ph-tpy)(dach)Cl]Cl (2) and [Ru(Cl-Ph-tpy)(bpy)Cl]Cl (3) (Cl-Ph-tpy = 4'-(4-chlorophenyl)-2,2':6',2''-terpyridine, en = 1,2-diaminoethane, dach = 1,2-diaminocyclohexane, bpy = 2,2'-bipyridine), with a mononucleotide guanosine-5'-monophosphate (5'-GMP) and oligonucleotides such as fully complementary 15-mer and 22-mer duplexes with a centrally located GG-binding site for DNA, and fully complementary 13-mer duplexes with a centrally located GG-binding site for RNA were studied quantitatively by UV-Vis spectroscopy. Duplex RNA reacts faster with complexes 1-3 than duplex DNA, while shorter duplex DNA (15mer GG) reacts faster compared with 22mer GG duplex DNA. The measured enthalpies and entropies of activation (ΔH≠ > 0, ΔS≠ < 0) support an associative mechanism for the substitution process. 1H NMR spectroscopy studies performed on complex 3 demonstrated that after the hydrolysis of the Cl ligand, it is capable to interact with guanine derivatives (i.e., 9-methylguanine (9MeG) and 5'-GMP) through N7, forming monofunctional adducts. The molecular structure of the cationic compound [Ru(Cl-Ph-tpy)(bpy)Cl]Cl (3) was determined in the solid state by X-ray crystallography. The interactions of 1-3 with calf thymus (CT) and herring testes (HT) DNA were examined by stopped-flow spectroscopy, in which HT DNA was sensibly more reactive than CT DNA. The reactivity towards the formation of Ru-DNA adducts was also revealed by a gel mobility shift assay, showing that complexes 1 and 2 have a stronger DNA unwinding ability compared to complex 3. Overall, the complexes with bidentate aliphatic diamines proved to be superior to those with bpy in terms of capability to bind to the here studied biomolecules.
Collapse
Affiliation(s)
- Milan M Milutinović
- University of Kragujevac, Faculty of Science, R. Domanovića 12, P. O. Box 60, 34000 Kragujevac, Serbia. and Lund University, Biochemistry and Structural Biology, KILU, P.O. Box 124, SE-221 00 Lund, Sweden
| | - Sofi K C Elmroth
- Lund University, Biochemistry and Structural Biology, KILU, P.O. Box 124, SE-221 00 Lund, Sweden
| | - Goran Davidović
- University of Kragujevac, Clinic for Cardiology, Clinical Center Kragujevac, Kragujevac, Serbia
| | - Ana Rilak
- University of Kragujevac, Faculty of Science, R. Domanovića 12, P. O. Box 60, 34000 Kragujevac, Serbia.
| | - Olivera R Klisurić
- University of Novi Sad, Faculty of Science, Department of Physics, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia
| | - Ioannis Bratsos
- I.N.N., Dept. of Physical Chemistry, NCSR "Demokritos", 15310 Ag. Paraskevi, Athens, Greece
| | - Živadin D Bugarčić
- University of Kragujevac, Faculty of Science, R. Domanovića 12, P. O. Box 60, 34000 Kragujevac, Serbia.
| |
Collapse
|
41
|
Understanding the interactions of diruthenium anticancer agents with amino acids. J Biol Inorg Chem 2018; 23:1159-1164. [DOI: 10.1007/s00775-018-1597-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2018] [Accepted: 07/05/2018] [Indexed: 12/27/2022]
|
42
|
Su W, Li Y, Xiao JA, Zhang Y, Li P. Synthesis, structure and antiproliferative activity of dinuclear ruthenium arene complexes with differently coordinated thiosemicarbazones. Appl Organomet Chem 2018. [DOI: 10.1002/aoc.4420] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Wei Su
- Key Laboratory of Guangxi Key Laboratory of Natural Polymer Chemistry and Physics (Guangxi Teachers Education University); Ministry of Education; Nanning China
| | - Yuchun Li
- Key Laboratory of Guangxi Key Laboratory of Natural Polymer Chemistry and Physics (Guangxi Teachers Education University); Ministry of Education; Nanning China
| | - Jun-an Xiao
- Key Laboratory of Guangxi Key Laboratory of Natural Polymer Chemistry and Physics (Guangxi Teachers Education University); Ministry of Education; Nanning China
| | - Yuexing Zhang
- Department of Chemistry; Hubei University; Wuhan 430062 China
| | - Peiyuan Li
- College of Pharmacy; Guangxi University of Chinese Medicine; Nanning China
| |
Collapse
|
43
|
Meier-Menches SM, Gerner C, Berger W, Hartinger CG, Keppler BK. Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development. Chem Soc Rev 2018; 47:909-928. [PMID: 29170783 DOI: 10.1039/c7cs00332c] [Citation(s) in RCA: 301] [Impact Index Per Article: 50.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Anticancer metallodrugs based on ruthenium and osmium are among the most investigated and advanced non-platinum metallodrugs. Inorganic drug discovery with these agents has undergone considerable advances over the past two decades and has currently two representatives in active clinical trials. As many ruthenium and osmium metallodrugs are prodrugs, a key question to be addressed is how the molecular reactivity of such metal-based therapeutics dictates the selectivity and the type of interaction with molecular targets. Within this frame, this review introduces the field by the examples of the most advanced ruthenium lead structures. Then, global structure-activity relationships are discussed for ruthenium and osmium metallodrugs with respect to in vitro antiproliferative/cytotoxic activity and in vivo tumor-inhibiting properties, as well as pharmacokinetics. Determining and validating global mechanisms of action and molecular targets are still major current challenges. Moreover, significant efforts must be invested in screening in vivo tumor models that mimic human pathophysiology to increase the predictability for successful preclinical and clinical development of ruthenium and osmium metallodrugs.
Collapse
Affiliation(s)
- Samuel M Meier-Menches
- University of Vienna, Department of Analytical Chemistry, Waehringer Str. 38, A-1090 Vienna, Austria.
| | | | | | | | | |
Collapse
|
44
|
Mohamed Kasim MS, Sundar S, Rengan R. Synthesis and structure of new binuclear ruthenium(ii) arene benzil bis(benzoylhydrazone) complexes: investigation on antiproliferative activity and apoptosis induction. Inorg Chem Front 2018. [DOI: 10.1039/c7qi00761b] [Citation(s) in RCA: 109] [Impact Index Per Article: 18.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
New binuclear Ru(ii) arene benzil bis(benzoylhydrazone) complexes show excellent cytotoxicity against human cancer cell lines. The results of biochemical assays demonstrated that complexes are able to induce apoptosis.
Collapse
Affiliation(s)
| | - Saranya Sundar
- Centre for Organometallic Chemistry
- School of Chemistry
- Bharathidasan University
- Tiruchirappalli 620 024
- India
| | - Ramesh Rengan
- Centre for Organometallic Chemistry
- School of Chemistry
- Bharathidasan University
- Tiruchirappalli 620 024
- India
| |
Collapse
|
45
|
Meiklejohn V, Depan D, Boudreaux SP, Murru S, Perkins RS, Fronczek FR, Srivastava RS. Ru( iii)–TMSO complexes containing azole-based ligands: synthesis and cytotoxicity study. NEW J CHEM 2018. [DOI: 10.1039/c7nj03267f] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The reaction of mer-[RuCl3(S-TMSO)2(O-TMSO)] with azoles in dichloromethane produced the complexes mer-[RuCl3(S-TMSO)(pzH)2], mer-[RuCl3(S-TMSO)(O-TMSO)(pzH)], mer-[RuCl3(S-TMSO)(dmpzH)2], and mer-[RuCl3(S-TMSO)(O-TMSO)(dmpzH)].
Collapse
Affiliation(s)
| | - Dilip Depan
- Department of Chemical Engineering, University of Louisiana at Lafayette
- Lafayette
- USA
| | - Seth P. Boudreaux
- New Iberia Research Center, University of Louisiana at Lafayette
- Lafayette
- USA
| | - Siva Murru
- Department of Chemistry, University of Louisiana at Lafayette
- Lafayette
- USA
| | - Richard S. Perkins
- Department of Chemistry, University of Louisiana at Lafayette
- Lafayette
- USA
| | | | | |
Collapse
|
46
|
Mass spectrometry as a powerful tool to study therapeutic metallodrugs speciation mechanisms: Current frontiers and perspectives. Coord Chem Rev 2017. [DOI: 10.1016/j.ccr.2017.02.012] [Citation(s) in RCA: 78] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
47
|
Branzan R, Sünkel K. 2‐Pyridylmetallocenes, Part VI. Double Cycloplatination of 1,1′‐Dipyridylferrocene. Synthesis and Molecular Structure of σ‐{Pt
2
Cl
2
(DMSO)
2
[Fe[η
5
‐(C
5
H
3
(2‐C
5
H
4
N)
2
]
2
]}. Z Anorg Allg Chem 2017. [DOI: 10.1002/zaac.201700264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ramona Branzan
- Department of Chemistry Ludwig Maximilians University Munich Butenandtstr. 9 81377 Munich Germany
| | - Karlheinz Sünkel
- Department of Chemistry Ludwig Maximilians University Munich Butenandtstr. 9 81377 Munich Germany
| |
Collapse
|
48
|
Zeng L, Gupta P, Chen Y, Wang E, Ji L, Chao H, Chen ZS. The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. Chem Soc Rev 2017; 46:5771-5804. [PMID: 28654103 PMCID: PMC5624840 DOI: 10.1039/c7cs00195a] [Citation(s) in RCA: 710] [Impact Index Per Article: 101.4] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Cancer is rapidly becoming the top killer in the world. Most of the FDA approved anticancer drugs are organic molecules, while metallodrugs are very scarce. The advent of the first metal based therapeutic agent, cisplatin, launched a new era in the application of transition metal complexes for therapeutic design. Due to their unique and versatile biochemical properties, ruthenium-based compounds have emerged as promising anti-cancer agents that serve as alternatives to cisplatin and its derivertives. Ruthenium(iii) complexes have successfully been used in clinical research and their mechanisms of anticancer action have been reported in large volumes over the past few decades. Ruthenium(ii) complexes have also attracted significant attention as anticancer candidates; however, only a few of them have been reported comprehensively. In this review, we discuss the development of ruthenium(ii) complexes as anticancer candidates and biocatalysts, including arene ruthenium complexes, polypyridyl ruthenium complexes, and ruthenium nanomaterial complexes. This review focuses on the likely mechanisms of action of ruthenium(ii)-based anticancer drugs and the relationship between their chemical structures and biological properties. This review also highlights the catalytic activity and the photoinduced activation of ruthenium(ii) complexes, their targeted delivery, and their activity in nanomaterial systems.
Collapse
Affiliation(s)
- Leli Zeng
- College of Pharmacy and Health Sciences, St. John's University, New York, NY 11439, USA.
| | | | | | | | | | | | | |
Collapse
|
49
|
Batchelor LK, Păunescu E, Soudani M, Scopelliti R, Dyson PJ. Influence of the Linker Length on the Cytotoxicity of Homobinuclear Ruthenium(II) and Gold(I) Complexes. Inorg Chem 2017; 56:9617-9633. [DOI: 10.1021/acs.inorgchem.7b01082] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Affiliation(s)
- Lucinda K. Batchelor
- Institut des Sciences et Ingénierie
Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - Emilia Păunescu
- Institut des Sciences et Ingénierie
Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - Mylène Soudani
- Institut des Sciences et Ingénierie
Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - Rosario Scopelliti
- Institut des Sciences et Ingénierie
Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - Paul J. Dyson
- Institut des Sciences et Ingénierie
Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| |
Collapse
|
50
|
Lazarević T, Rilak A, Bugarčić ŽD. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives. Eur J Med Chem 2017; 142:8-31. [PMID: 28442170 DOI: 10.1016/j.ejmech.2017.04.007] [Citation(s) in RCA: 260] [Impact Index Per Article: 37.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2017] [Revised: 03/30/2017] [Accepted: 04/03/2017] [Indexed: 11/18/2022]
Abstract
Metallodrugs offer potential for unique mechanism of drug action based on the choice of the metal, its oxidation state, the types and number of coordinated ligands and the coordination geometry. This review illustrates notable recent progress in the field of medicinal bioinorganic chemistry as many new approaches to the design of innovative metal-based anticancer drugs are emerging. Current research addressing the problems associated with platinum drugs has focused on other metal-based therapeutics that have different modes of action and on prodrug and targeting strategies in an effort to diminish the side-effects of cisplatin chemotherapy. Examples of metal compounds and chelating agents currently in clinical use, clinical trials or preclinical development are highlighted.
Collapse
Affiliation(s)
- Tatjana Lazarević
- University of Kragujevac, Faculty of Medicine, S. Marković 69, 34000, Kragujevac, Serbia
| | - Ana Rilak
- University of Kragujevac, Faculty of Science, R. Domanovića 12, P. O. Box 60, 34000 Kragujevac, Serbia.
| | - Živadin D Bugarčić
- University of Kragujevac, Faculty of Science, R. Domanovića 12, P. O. Box 60, 34000 Kragujevac, Serbia.
| |
Collapse
|